Growth of the Helicobacter Pylori (H. pylori) Non-Invasive Testing Market

The market for Helicobacter Pylori (H. pylori) non-invasive testing is projected to expand from US$ 596.82 million in 2021 to US$ 800.04 million by 2028, reflecting a compound annual growth rate (CAGR) of 4.4% from 2022 to 2028.

This growth is driven by several factors, including the rising incidence of H. pylori infections, increased public awareness regarding the importance of H. pylori diagnosis, and the introduction of new products along with FDA approvals that enhance market dynamics.

Notably, the occurrence of gastric diseases is significantly elevated among the elderly, as the risk of H. pylori infection escalates with age. As individuals grow older, the stomach lining tends to thin, which facilitates the bacteria's ability to breach the protective barrier, thereby increasing infection rates in older populations. According to the World Health Organization (WHO), by 2030, the global population aged 60 and above is expected to reach 13.7%, with the Southeast Asia region projected to have 20.3% of its population in this age group. This demographic shift is likely to heighten the demand for primary healthcare services, including screening, evaluation, and management of related health issues, thereby propelling the need for diagnostic solutions worldwide and fostering growth in the H. pylori non-invasive testing market.

Segmental Analysis of the H. pylori Non-Invasive Testing Market

The H. pylori non-invasive testing market can be categorized based on test type, testing method, and end users. In terms of test type, the market is divided into serology, stool antigen, and urea breath tests. The urea breath test segment dominated the market in 2021 and is expected to exhibit the highest CAGR during the forecast period, driven by ongoing product development initiatives from key industry players.

When examining testing methods, the market is split into laboratory-based and point-of-care (POC) testing. The laboratory-based segment held a larger market share in 2021 and is anticipated to grow at a faster rate from 2022 to 2028, as healthcare professionals increasingly rely on these procedures for accurate diagnostics.

As for end users, the market is segmented into hospitals, clinics, and diagnostic laboratories. In 2021, diagnostic laboratories accounted for the largest market share and are projected to experience the highest CAGR through 2028, attributed to the growing volume of tests conducted in laboratories and the competitive nature of the industry, which demands high-quality services at competitive prices.

Geographical Insights into the H. pylori Non-Invasive Testing Market

North America currently holds the largest share of the global H. pylori non-invasive testing market, while the Asia Pacific region is recognized as the fastest-growing area. The North American market is expected to expand during the forecast period, driven by the increasing rates of stomach cancer, duodenal ulcers, and gastric ulcers, alongside advancements in healthcare facilities.

Conversely, the Asia Pacific region is projected to achieve the highest CAGR in the H. pylori non-invasive testing market over the forecast period. Countries such as China, India, and Japan are expected to see significant market growth due to their aging populations, high prevalence of H. pylori infections, and rising cases of gastric cancer. This region presents substantial opportunities for market players looking to expand their presence.

Opportunities in the H. pylori Non-Invasive Testing Market

Global conferences and events organized by various institutions play a crucial role in raising awareness about H. pylori infections, emphasizing the importance of timely screening, early diagnosis, and effective treatment options. Participants at these events often leverage the insights gained to develop frameworks for implementing H. pylori testing devices in their healthcare practices. For example, the "Helicobacter pylori Update Conference" held in Abu Dhabi in February 2019 provided a platform for interaction with leading experts in scientific research, public health, and industry.

The growing awareness of H. pylori-related conditions, such as peptic ulcers and gastritis, is facilitating the availability of diagnostic kits that can be used conveniently at home, thus creating additional growth avenues for the H. pylori non-invasive testing market. Many healthcare professionals advocate for point-of-care testing as a critical tool for the early detection of serious health issues, given that results can be obtained in real-time. In low- and middle-income countries, POC diagnostic devices are expected to become commonplace in homes and healthcare facilities. Additionally, companies are introducing home-use test kits, such as the Biocard Helicobacter pylori IgG test by Labsystems Diagnostics, which allows for the detection of H. pylori IgG antibodies at home.

In summary, the combination of increased awareness, the rise of POC testing, and the ongoing development of innovative diagnostic solutions is likely to create significant growth opportunities for the H. pylori non-invasive testing market in the years to come.

Key secondary sources utilized in the preparation of this report include the World Health Organization (WHO), Globocan, World Bank Data, National Health Service (NHS), PubMed Central, and National Center for Biotechnology Information (NCBI).